Beam Therapeutics Inc. (BEAM) Technical Analysis & Indicators

Beam Therapeutics Inc. (BEAM) — Price $27.23 (closing price, October 30, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Beam Therapeutics Inc. (BEAM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia.

Price Performance

1 month+11.14%
3 months+5.09%
Year-to-date-1.77%
1 year+8.88%
3 years+27.01%
5 years-71.84%

52-Week Range

52-week High$38.26
52-week Low$20.23
Avg Volume (90d)2.0M

Technical Indicators

SMA 50$25.93
SMA 200$28.14
Beta2.19
30-day Volatility (annualised)62.0%
Price vs SMA 50+5.0%
Price vs SMA 200-3.2%

Monthly Close (12 months)

MonthCloseChange
2025-12$27.72
2026-01$27.62-0.4%
2026-02$28.46+3.0%
2026-03$23.83-16.3%
2026-04$30.33+27.3%
2026-05$32.93+8.6%
2026-06$34.32+4.2%
2026-07$25.52-25.6%
2026-08$29.43+15.3%
2026-09$24.45-16.9%
2026-10$27.23+11.4%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-11-03$-1.15$9M
2026-08-04$-1.11$16M
2026-05-07$-0.87$11M
2026-02-24$-1.13$12M
2025-11-04$-0.98$13M
2025-08-05$-1.04$12M
2025-05-06$-1.11$16M

Price

Price$27.23 (closing price, October 30, 2026)
Market Cap$2.8B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book2.66
EV / EBITDA-44.95
Dividend Yield0.00%

Financial Health

Debt / Equity0.23
Current Ratio14.57
Piotroski F-Score4
Altman Z-Score5.41

Related companies: CRSP · VRTX · 0QZU.L · REGN · MRNA · 0R2M.L · ARGX · 0QNO.L

Explore sector: Healthcare · Biotechnology

More sections of BEAM: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks